当前位置:首页 / 基于数据挖掘技术探讨中药治疗肝炎后肝硬化的用药规律
论著.中医药与民族医药诊疗 | 更新时间:2025-07-18
|
基于数据挖掘技术探讨中药治疗肝炎后肝硬化的用药规律
Medication rules of Traditional Chinese Medicine for the treatment of posthepatitic cirrhosis based on data mining technique: an exploration study

广西医学 页码:841-847

作者机构:罗茂权,硕士,住院医师,研究方向为中西医结合防治脾胃病的基础研究。

基金信息:科技攻关与新产品试制(2022SB020)

DOI:10.11675/j.issn.0253⁃4304.2025.06.11

  • 中文简介
  • 英文简介
  • 参考文献

目的 基于数据挖掘技术探讨中药治疗肝炎后肝硬化的用药规律。方法 检索中国知网数据库,筛选中药治疗肝炎后肝硬化的文献,纳入相关中药处方并建立数据库。采用Microsoft Excel 2021软件对中药的使用频次、药性、药味、归经、功效进行描述性统计分析。采用IBM SPSS Modeler 18.0软件对药物进行关联规则分析,采用IBM SPSS Statistics 25.0软件进行系统聚类分析。结果 共纳入文献191篇,涉及中药处方222首,包含236味中药。其中,使用频次≥30次的中药(高频中药)有29味,排名前5的中药依次为白术、茯苓、丹参、黄芪、鳖甲。236味中药的药性以寒性为主,其次为温性、平性;药味以苦味、甘味、辛味为主;主要归于脾经、肝经、胃经、肺经、心经;中药功效以补虚、活血化瘀、利水渗湿为主。关联规则分析得到二联药物组合1组,三联药物组合4组,四联药物组合11组,五联药物组合3组,核心药物包括白术、茯苓、丹参、黄芪、鳖甲等。通过系统聚类分析,结合中药功效知识,可将29味高频中药聚类为8类。结论 中药治疗肝炎后肝硬化用药多以健脾疏肝、活血化瘀、清热解毒利湿为主,常用茯苓、白术、丹参、鳖甲、黄芪等药物,秉持多药并用,标本兼治原则。

Objective To explore the medication rules of Traditional Chinese Medicine for the treatment of posthepatitic cirrhosis based on data mining technique. Methods Literature on Traditional Chinese Medicine for the treatment of posthepatitic cirrhosis was retrieved from the China National Knowledge Infrastructure database, and relevant Traditional Chinese Medicine prescriptions were screened and enrolled for a database construction. Descriptive statistical analysis was performed using Microsoft Excel 2021 to evaluate the frequency of use, properties, flavors, meridians, and efficacy of Traditional Chinese Medicines. Association rule analysis was conducted using IBM SPSS Modeler 18.0 software, and systematic cluster analysis was performed using IBM SPSS Statistics 25.0 software. Results A total of 191 literature was included, involving 222 Traditional Chinese Medicine prescriptions and 236 flavors of Traditional Chinese Medicines. Among them, 29 high⁃frequency Traditional Chinese Medicines (used ≥30 times) were identified, with the top 5 being Atractylodes macrocephala, Poria cocos, Salvia miltiorrhiza, Astragalus membranaceus, and Trionycis carapax. The properties of the 236 Traditional Chinese Medicines were primarily cold, followed by warm and moderate, the flavors were mainly bitter, sweet, and acrid; the meridians primarily belonged to spleen meridian, liver meridian, stomach meridian, lung meridian, and heart meridian, and the main efficacy was tonifying deficiency, activating blood circulation and resolving stasis, and promoting diuresis and draining dampness. Association rule analysis yielded 1 pair of two⁃drug combinations, 4 three⁃drug combinations, 11 four⁃drug combinations, and 3 five⁃drug combinations, with core drugs including Atractylodes macrocephala, Poria cocos, Salvia miltiorrhiza, Astragalus membranaceus, and Trionycis carapax. Through systematic cluster analysis and combined with Traditional Chinese Medicine efficacy knowledge, the 29 high⁃frequency Traditional Chinese Medicines were clustered into 8 categories. Conclusion Traditional Chinese Medicine for the treatment of posthepatitic cirrhosis primarily focuses on strengthening spleen and soothing liver, activating blood circulation and resolving stasis, and clearing heat, detoxifying, and draining dampness. Commonly used drugs include Poria cocos, Atractylodes macrocephala, Salvia miltiorrhiza, Trionycis carapax, and Astragalus membranaceus, adhering to the principle of combining multiple drugs and addressing both symptoms and root causes.  

19

浏览量

0

下载量

0

CSCD

工具集